Blue Owl Capital: Navigating Legal Headwinds and Strategic Shifts
17.01.2026 - 18:31:04Investors in Blue Owl Capital are currently weighing a complex mix of legal challenges and strategic initiatives. The alternative asset manager faces multiple class-action lawsuits alleging misleading statements and concealed liquidity issues within its Business Development Companies (BDCs). Concurrently, the firm is actively pursuing expansion into the private asset secondary market, a move that has generated some cautious optimism.
In a significant strategic pivot, Blue Owl is advancing plans to grow its presence in the private fund secondary market. This involves acquiring fund interests from investors seeking liquidity, utilizing capital from its strategic equity division. The company aims to capitalize on a record-breaking secondary market, which reached $226 billion in transaction volume during 2025. To lead this charge, Blue Owl has announced its intention to hire a dedicated executive to develop relationships, particularly with institutional Limited Partners. This strategic announcement provided a modest boost to the share price, leading to an interim gain of approximately 1.2%.
Legal and Operational Pressures
Counterbalancing this growth narrative is substantial legal and operational pressure. The class-action suits, which question the transparency of the BDCs' operational health, have a direct bearing on shareholders. The deadline for investors to join these actions is February 2, 2026.
Operational results for the third quarter of 2025 further dampened sentiment. The company reported total fee-related earnings (FRE) of $376.2 million, falling short of consensus estimates. On a per-share basis, FRE came in at $0.24. The FRE margin of 57.1% missed expectations by about 20 basis points. Perhaps more strikingly, performance revenues declined by 33% year-over-year to just $188,000.
Adding to the uncertainty, a planned consolidation of its BDCs was called off in November 2025, officially attributed to "current market conditions." This confluence of legal risk, weaker performance earnings, and a failed strategic transaction has fostered a cautious investor outlook.
Should investors sell immediately? Or is it worth buying Blue Owl Capital?
Analyst Views and Valuation Metrics
Market analyst opinions remain divided, reflecting the company's mixed signals. Price target ranges are broad, spanning from $18 to $28 per share, with a consensus target sitting at $22. Some firms, such as Raymond James, view the stock as attractively valued based on P/E considerations, while other valuation models suggest a significantly lower fair value.
As of the latest close, Blue Owl shares ended the Friday session at $15.79. This price sits roughly 39% below its 52-week high. The stock offers a dividend yield of 5.61%, supported by a 25% increase in the payout over the prior year.
Summary of Key Points:
- Multiple class-action lawsuits allege misleading disclosures and liquidity concerns in Blue Owl's BDCs. Shareholder participation deadline is February 2, 2026.
- Q3 2025 results disappointed: FRE of $376.2M (below consensus), FRE/share of $0.24, and a 33% drop in performance revenue to $188k.
- Strategic push into the $226 billion (2025 volume) secondary market is underway, with new leadership recruitment planned.
Conclusion: In the near term, legal overhangs and disappointing performance-based earnings are likely to dominate the valuation conversation. While the secondary market strategy could unlock new revenue streams in the medium term, it is unlikely to immediately resolve the present uncertainties. The key factors for investors to monitor will be the progression of the class-action litigation, a turnaround in operational performance revenues, and tangible progress in building out the secondary market business.
Ad
Blue Owl Capital Stock: Buy or Sell?! New Blue Owl Capital Analysis from January 17 delivers the answer:
The latest Blue Owl Capital figures speak for themselves: Urgent action needed for Blue Owl Capital investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 17.
Blue Owl Capital: Buy or sell? Read more here...


